Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03692182 · ClinicalTrials.gov registry record
The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)
A clinical trial, sponsored by Tabula Rasa HealthCare.
- Completed
- Registry status
- 10,000
- Enrollment target
NCT03692182: Completed study, sponsored by Tabula Rasa HealthCare.
NCT03692182 is a clinical trial that has completed, run by Tabula Rasa HealthCare. The registered enrollment target is 10,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03692182 has completed, sponsored by Tabula Rasa HealthCare.
- COMPLETED
- Registry status
- 10,000 participants
- Enrollment target
Study Summary
The aim of this study is to retrospectively evaluate and describe the use of antipsychotics among participants enrolled in the Program of All-inclusive Care for the Elderly (PACE), a community-based practice setting.
Primary Outcome
Quantitative description of antipsychotic use as assessed by pharmacy records
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-03 |
What the finished NCT03692182 record still lists
NCT03692182 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03692182 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03692182 about?
NCT03692182 is a clinical study titled "The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)". The aim of this study is to retrospectively evaluate and describe the use of antipsychotics among participants enrolled in the Program of All-inclusive Care for the Elderly (PACE), a community-based practice setting.
What is the current status of trial NCT03692182?
This trial is currently completed. The enrollment target is 10,000 participants. The study started on 2017-01. Estimated completion is 2019-03.
Who is sponsoring clinical trial NCT03692182?
This trial is sponsored by Tabula Rasa HealthCare, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia